Population-based evidence of increased survival in human papillomavirus-related head and neck cancer
Introduction
Recently, an increase in the incidence of oropharyngeal cancer has been observed in Europe and the United States (US).1, 2, 3, 4 In Norway, oropharyngeal cancer rates exhibited a mean annual increase of 5% in contrast to declining trends of tumours of other pharyngeal sites.5 Increased exposure to infection with high-risk human papillomavirus (HPV) types and reduced exposure to tobacco in the population have been proposed as explanations.
Prognosis for the heterogenic group of pharyngeal cancers is relatively poor, with a five-year relative survival rate of about 30% in Norway in the diagnostic period 1999–2003.6 Of particular interest, however, is the fact that patients with detectable HPV in their oropharyngeal tumors have been observed to have 1.4–2.7 times better survival relative to same-tumour patients tested negative for HPV.7, 8, 9
Among head and neck squamous cell carcinomas (HNSCC), HPV DNA is most readily detected in oropharyngeal tumours.10, 11 The proportion of oropharyngeal cancers containing HPV DNA ranges from almost two-thirds to 90%.10, 12 Oropharyngeal cancers diagnosed in the last decade have been shown to harbour HPV DNA two to four times more frequently than such cancers diagnosed in the 1970s.9, 12, 13 HPV type 16 was the most commonly detected of 15 oncogenic HPV types,14 being found in 90–95% of HPV-positive cancers. Based on data emerging from clinical and microbiological studies, it has been suggested that HPV-positive HNSCCs are a distinct biological entity.2, 15, 16
In the current study we are using data from the population-based Cancer Registry of Norway and describe time trends in oral, pharyngeal and laryngeal cancer incidence rates and survival proportions over the period 1981–2007, dichotomised into categories that recognise subsites, on the basis of existing epidemiological evidence, as being broadly HPV-related or HPV-unrelated HNSCCs.
Section snippets
Material and methods
Incident cases of HNSCC extracted from the national, population-based Cancer Registry of Norway in 1981–2007 were categorised as HPV-related (HPV+HNSCC) or HPV-unrelated (HPV–HNSCC).16, 17 Cancers of the base of tongue, tonsils and oropharynx (International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD 10): C01,C09–10), all oropharyngeal sites according to the TNM Classification,18, 19 were defined as HPV+HNSCC, and cancers of mobile tongue, floor of
Results
Fig. 1 shows the age-specific all cause survival proportions together with a number of patients alive at the beginning of each follow-up year, separately for patients with HPV+HNSCC (panels A and B) and HPV–HNSCC (Panels C and D), in 1981–1995 (panels A and C) and 1996–2007 (panels B and D). Median age at diagnosis for HPV+HNSCC patients was 63.2 years in 1981–1995, and 59.8 years in 1996–2007. For HPV–HNSCC patients, median age at diagnosis was 66.6 years in both periods. The proportion of
Discussion
Our population-based study provides further evidence that anatomic sites of the mouth and oropharynx acquired different risk profiles with respect to cancer over the past three decades in Norway. Given the concomitant increase in the incidence of and survival from oropharyngeal cancer, our results support the notion of an emerging and distinct group of head and neck cancers located within oropharynx. Cancers of the base of the tongue, tonsils and oropharynx are known to be common aetiological
Conflict of interest statement
None declared.
References (32)
- et al.
Oral and oropharyngeal cancer in The Netherlands between 1989 and 2006: increasing incidence, but not in young adults
Oral Oncol
(2009) - et al.
HPV-associated head and neck cancer: a virus-related cancer epidemic
Lancet Oncol
(2010) - et al.
Oropharyngeal cancer incidence and mortality in Scotland: are rates still increasing?
Oral Oncol
(2003) Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity
Semin Oncol
(2004)- et al.
Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial
Lancet
(2003) - et al.
Differential survival trends for patients with tonsillar, base of tongue and tongue cancer in Sweden
Oral Oncol
(2011) - et al.
Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness
Eur J Cancer
(2009) - et al.
Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States
J Clin Oncol
(2008) - et al.
Time trends in pharyngeal cancer incidence in Norway 1981–2005: a subsite analysis based on a reabstraction and recoding of registered cases
Cancer Causes Control
(2010) - et al.
Trends in the survival of patients diagnosed with cancers of the lip, oral cavity, and pharynx in the Nordic countries 1964–2003 followed up to the end of 2006
Acta Oncol
(2010)
Human papillomavirus and survival of patients with oropharyngeal cancer
N Engl J Med
Human papillomavirus and survival in patients with base of tongue cancer
Int J Cancer
Human papillomavirus (HPV)-positive tonsillar carcinomas are frequent and have a favourable prognosis in males in Norway
Acta Otolaryngol
Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study
J Natl Cancer Inst
Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review
Cancer Epidemiol Biomarkers Prev
Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?
Int J Cancer
Cited by (45)
The prognostic role of 18F-fluorodeoxyglucose PET in head and neck cancer depends on HPV status
2019, Radiotherapy and OncologyCitation Excerpt :Next, we split the dataset into HPV-related (n = 93) and HPV-unrelated groups (n = 73). HPV-related cancer was defined as HPV positive OPC [3,44]. HPV-unrelated cancer was defined as HPV negative OPC or non-OPC (oral cavity, hypopharyngeal or laryngeal cancer) regardless of HPV status.
Timing of HPV16-E6 antibody seroconversion before OPSCC: Findings from the HPVC3 consortium
2019, Annals of OncologyRising Incidence and Improved Survival of Anal Squamous Cell Carcinoma in Norway, 1987-2016
2019, Clinical Colorectal CancerCitation Excerpt :This is in line with the finding of increased incidence of other HPV-induced cancers, in particular cancer of the oropharynx.3,37 The increase in HPV-related head and neck cancers in Norway has been even larger than for anal cancer, with an average percentage change of 4.6 and 4.0 for men and women, respectively.38 Both major morphological types of cervical cancer, squamous cell carcinoma (SCC) and adenocarcinoma, are causally related to persistent infection with high-risk HPV; however, screening is only effective for detecting SCC.
Base of tongue cancer—is it tongue cancer located at the base of the tongue, or is it a type of lingual tonsil cancer? The perspective from a genomic analysis
2018, International Journal of Oral and Maxillofacial Surgery